WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Synaptic Systems Antibody Company
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 24, 2007, 27(4):751-761; doi:10.1523/JNEUROSCI.4800-06.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billings, L. M.
Right arrow Articles by LaFerla, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billings, L. M.
Right arrow Articles by LaFerla, F. M.

 Previous Article  |  Next Article 

Neurobiology of Disease
Learning Decreases Aß*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice

Lauren M. Billings,1,2 * Kim N. Green,1,2 * James L. McGaugh,1 and Frank M. LaFerla1,2

1Department of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory and 2Institute for Brain Aging and Dementia, University of California, Irvine, Irvine, California 92697-4545

Correspondence should be addressed to Frank M. LaFerla, Department of Neurobiology and Behavior, University of California, Irvine, 1109 Gillespie Neuroscience Building, Irvine, CA 92697-4545. Email: laferla{at}uci.edu

Transgenic mouse models of Alzheimer's disease (AD), such as the 3xTg-AD mice, are instrumental for elucidating genetic, pharmacologic, environmental, and behavioral factors that affect the cognitive phenotype. Here we present the novel findings that longitudinal water-maze spatial training produces a significant, albeit transient, improvement in subsequent learning performance and reduces amyloid ß (Aß) and tau neuropathology. The 3xTg-AD mice were trained and tested at 3 month intervals from 2 to 18 months. Separate groups of naive mice were also tested at each age. The improvement in performance seen at 6 and 12 months is dependent on spatial training, because animals that were similarly handled and exposed to swimming without a learning contingency failed to show improved performance. Training before the development of overt neuropathology is required for full expression of the training effect because we found it delays Aß redistribution to extracellular plaques and reduces Aß oligomers associated with cognitive decline. In addition, learning leads to decreased glycogen synthase kinase-3ß activity, which likely underlies the reduced tau pathology. The previous training effects on both maze performance and neuropathology are attenuated at 15 and 18 months. These findings indicate that, in young and middle-aged 3xTg-AD mice, repeated spatial training can significantly delay the development of neuropathology and decline in spatial memory.

Key words: tau; Alzheimer's disease; amyloid ß; behavior; cognition; transgenic


Received Aug. 11, 2006; revised Dec. 8, 2006; accepted Dec. 10, 2006.

Correspondence should be addressed to Frank M. LaFerla, Department of Neurobiology and Behavior, University of California, Irvine, 1109 Gillespie Neuroscience Building, Irvine, CA 92697-4545. Email: laferla{at}uci.edu




This article has been cited by other articles:


Home page
Learn. Mem.Home page
S. Daumas, J. Sandin, K. S. Chen, D. Kobayashi, J. Tulloch, S. J. Martin, D. Games, and R. G.M. Morris
Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: Deficit in memory retrieval associated with increased sensitivity to interference?
Learn. Mem., August 26, 2008; 15(9): 625 - 632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Terwel, D. Muyllaert, I. Dewachter, P. Borghgraef, S. Croes, H. Devijver, and F. Van Leuven
Amyloid Activates GSK-3{beta} to Aggravate Neuronal Tauopathy in Bigenic Mice
Am. J. Pathol., March 1, 2008; 172(3): 786 - 798.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. C. Carroll, E. R. Rosario, L. Chang, F. Z. Stanczyk, S. Oddo, F. M. LaFerla, and C. J. Pike
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
J. Neurosci., November 28, 2007; 27(48): 13357 - 13365.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
G. R Seabrook, W. J. Ray, M. Shearman, and M. Hutton
BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
Mol. Interv., October 1, 2007; 7(5): 261 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. N. Green, H. Martinez-Coria, H. Khashwji, E. B. Hall, K. A. Yurko-Mauro, L. Ellis, and F. M. LaFerla
Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-{beta} and Tau Pathology via a Mechanism Involving Presenilin 1 Levels
J. Neurosci., April 18, 2007; 27(16): 4385 - 4395.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-